Total Funding
42
58
Total FundingSeed raised
Growth Score
-3 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
45264
‘Off-the-Shelf’ Curative Cell Therapies
- Ajay Vishwakarma: Founder and CEO
- Alexey Bersenev: Co-founder and CTO
About the Company
Cell BioEngines, Inc., founded in Dec 2022, is a clinical-stage biotech company focused on developing allogeneic 'off-the-shelf' stem cell and its derived therapies as ‘drugs’ for treating human diseases.
The company is developing a transgene-free “super-donor” stem cell platform designed to reprogram cell fate and function for the
treatment of serious and currently incurable diseases. Cell BioEngines’ competitive edge lies in scalable manufacturing of chemically reprogrammed stem cells without genetic engineering, combined with HLA-guided design and a population-informed biobank for broad patient coverage.
For more information, visit www.cellbioengines.com
